* Pediatrix Medical Group Inc MD.N MD is expected
to show a
rise in quarterly revenue when it reports results on August 3.
* The Sunrise Florida-based company is expected to report
a
2.0% increase in revenue to $495.856 million from $486.03
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Pediatrix Medical
Group
Inc is for earnings of 40 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 5
"hold" and 3 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Pediatrix
Medical
Group Inc is $15, above its last closing price of $13.73.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 0.23 0.23 0.23 Met 0.5
Dec. 31 2023 0.49 0.48 0.47 Missed -2.8
Sep. 30 2022 0.54 0.55 0.40 Missed -26.9
Jun. 30 2022 0.48 0.48 0.47 Missed -1.1
Mar. 0.27 0.27 0.33 Beat 21.1
31 2022
Dec. 31 2021 0.44 0.44 0.52 Beat 19.2
Sep. 30 2021 0.42 0.42 0.46 Beat 10.6
Jun. 30 2021 0.32 0.32 0.41 Beat 26.4
This summary was machine generated August 1 at 18:37 GMT. All
figures in US dollars unless otherwise stated